TUNEL - an efficient prognosis predictor of salivary malignancies.

Ben-Izhak, O; Laster, Z; Araidy, S; Nagler, R M

Ben-Izhak, O; Laster, Z; Araidy, S; Nagler, R M.

Affiliation

Ben-Izhak O; Department of Pathology, Rambam Medical Center, Haifa, Israel.

Br J Cancer ; 96(7): 1101-6, 2007 Apr 10.

Article in En | MEDLINE | ID: mdl-17325701

Subject(s)

Apoptosis; In Situ Nick-End Labeling; Salivary Gland Neoplasms/pathology; Adenocarcinoma/metabolism; Adenocarcinoma/pathology; Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor/metabolism; Carcinoma, Adenoid Cystic/metabolism; Carcinoma, Adenoid Cystic/pathology; Carcinoma, Mucoepidermoid/metabolism; Carcinoma, Mucoepidermoid/pathology; Carcinoma, Squamous Cell/metabolism; Carcinoma, Squamous Cell/pathology; Female; Humans; Ki-67 Antigen/metabolism; Male; Middle Aged; Predictive Value of Tests; Prognosis; Salivary Gland Neoplasms/metabolism; Survival Rate; Tumor Suppressor Protein p53/metabolism

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Salivary Gland Neoplasms / Apoptosis / In Situ Nick-End Labeling Type of study: Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2007 Document type: Article Affiliation country: Israel Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google